Folotyn for Non-Hodgkin's Lymphoma Massapequa NY

The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday. The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

Local Companies

MIR IQBAL, MD
(516) 735-9210
4277 Hempstead Tpk
Bethpage, NY
UZMA IQBAL, MD
(718) 470-8939
27005 76Th Avenue
New Hyde Park, NY
Mark Mehrdad Moasser, MD
718-380-8080
16416 76th Rd
Fresh Meadows, NY
Philip George Scimeca, MD
516-562-4634
200 Old Country Rd Ste 440
Mineola, NY
Tiffany A TrosO'Sandoval, MD
650 Commack Rd
Commack, NY
Farida P Chaudhri MD
(718) 358-3057
146-01 45th Ave
Flushing, NY
LAURA DONAHUE, MD
(516) 734-8971
450 Lakeville Road
New Hyde Park, NY
Nasir Mahmood Gondal, MD
718-263-7766
11247 Queens Blvd Ste 209
Forest Hills, NY
Viorica Goya, MD
15211 89th Ave
Jamaica, NY
Louis Potters, MD
516-632-3370
1 Healthy Way
Oceanside, NY
Data Provided by:
    

Provided By:

FRIDAY, Sept. 25 (HealthDay News) -- The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday.

The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

PTCL strikes fewer than 9,500 people each year in the United States, the FDA said. The disease affects a type of white blood cell, called a T-cell, involved in the body's disease-fighting immune system.

Approval of Folotyn was based on clinical data showing it reduced tumor size in 27 percent of 109 people with PTCL who were studied. The most common adverse reactions included sores of the lips, mouth and digestive tract, low white blood cell counts, fever, nausea and fatigue.

Since the drug can harm a fetus, women taking Folotyn should avoid becoming pregnant, the FDA said. Anyone taking the drug should also take folate and vitamin B12 supplements to help reduce irritation of the mucous membranes.

Folotyn is produced by Colorado-based Allos Therapeutics, which is required to conduct additional studies of tumor shrinkage and life expectancy, the agency said.

More information

The FDA has more about this drug.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Donor Stem-Cell Transplant for Acute Myeloid Leukemia Massapequa NY
For most patients with acute myeloid leukemia (AML) who come out of remission, donor stem cells appear to offer the best shot at survival, a new analysis shows.
- Green Tea and Hematologic Malignancies Massapequa NY